PD-L1 over-expression and survival in patients with non-small cell lung cancer: a meta-analysis.
about
PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis.Evaluation of PD-L1 Expression in Tumor Tissue of Patients with Lung Carcinoma and Correlation with Clinical and Demographic Data.The correlation between programmed death-ligand 1 expression and driver gene mutations in NSCLC.The expression status and prognostic significance of programmed cell death 1 ligand 1 in gastrointestinal tract cancer: a systematic review and meta-analysisPD-L1 Expression and Survival among Patients with Advanced Non-Small Cell Lung Cancer Treated with ChemotherapyAre immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?-current evidence and future perspectives.New PD-L1 inhibitors in non-small cell lung cancer - impact of atezolizumab.Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma.Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer.Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor NivolumabComparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literature.BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis.Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis.
P2860
Q26741101-C251BFF1-5C17-4F3A-A384-8BB5CCBAE835Q27853291-31213AEF-35EF-45FB-8FD0-FF8279B20DB7Q31137039-E2213A76-53BE-4CC1-B62B-D8F13CB9E289Q33618747-BBAC433F-DE2C-4B98-A5CA-B6FD5CCBFFCDQ36116591-5336D3EE-AA73-424E-A536-289EA6312262Q36707123-2875DED4-8C52-4920-BDF9-8518FA40CA1AQ37584395-B511F26C-C0D3-4A26-A2DB-35066B19D6BFQ38648979-2EBDC837-3472-451E-BC0F-B59BA3E2C298Q38907925-B1DBF631-E4E2-4403-8F07-78FA7AE465F3Q38930084-521CAA77-A9DE-419E-AF95-3949E6BFBF3CQ41333886-D496E8BB-82AB-402B-9F69-95881D07BDAEQ47727627-6E319A21-55AA-4873-A474-DB4FA9195D73Q47862701-EFB60537-CF57-40A2-A0D7-18108F7D68FAQ55440274-2F41689F-7178-46FA-B305-75AF75DC18F0
P2860
PD-L1 over-expression and survival in patients with non-small cell lung cancer: a meta-analysis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
PD-L1 over-expression and surv ...... lung cancer: a meta-analysis.
@ast
PD-L1 over-expression and surv ...... lung cancer: a meta-analysis.
@en
type
label
PD-L1 over-expression and surv ...... lung cancer: a meta-analysis.
@ast
PD-L1 over-expression and surv ...... lung cancer: a meta-analysis.
@en
prefLabel
PD-L1 over-expression and surv ...... lung cancer: a meta-analysis.
@ast
PD-L1 over-expression and surv ...... lung cancer: a meta-analysis.
@en
P2093
P2860
P1476
PD-L1 over-expression and surv ...... lung cancer: a meta-analysis.
@en
P2093
P2860
P304
P356
10.3978/J.ISSN.2218-6751.2015.03.02
P577
2015-04-01T00:00:00Z